METHODS	At the end of run-in , subjects were randomly assigned to receive sc-FOS ( Actilight ) ( 10.6 g/day ) or placebo ( maltodextrine plus aspartame 15 g/day ) with tea and/or coffee for a duration of 2 months and thereafter switched to the other treatment for additional 2 months .\